Scott Applebaum's Net Worth

$245 Thousand

Estimate Recalculated Jul 2, 2024 07:03PM EST

Who is Scott Applebaum?

Scott Applebaum does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include TREVENA INC, Cingulate Inc., MEDGENICS, INC., and Vitae Pharmaceuticals, Inc.

SEC CIK

Scott Applebaum's CIK is 0001618945

Past Insider Trading and Trends

2020 was Scott Applebaum's most active year for acquiring shares with 4 total transactions. Scott Applebaum's most active month to acquire stocks was the month of November. 2016 was Scott Applebaum's most active year for disposing of shares, totalling 1 transactions. Scott Applebaum's most active month to dispose stocks was the month of January. 2014 saw Scott Applebaum paying a total of $25,001.80 for 456,098 shares, this is the most they've acquired in one year. In 2016 Scott Applebaum cashed out on 150,000 shares for a total of $1,837,500.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

TREVENA INC (TRVN) Snapshot price: $0.61

CLCO; SVP, Regulatory Affairs

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-5.80%
-21.18K
$2.85
-$60,357.30
344.02K
Feb 10
Form 4
+46.08%
115.2K
—
—
365.2K
Dec 17
Form 4
∞
250K
—
—
250K
Feb 10
Form 3
—
0
—
—
0
No matching records found

Cingulate Inc. (CING) Snapshot price: $1.0679

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Aug 9
Form 3
—
0
—
—
0
No matching records found

MEDGENICS, INC. No price found

Chief Legal Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Apr 15
Form 4
∞
6.1K
$4.10
$25,001.80
6.1K
Dec 1
Form 4
—
0
—
—
0
Sep 8
Form 3
—
0
—
—
0
No matching records found

Vitae Pharmaceuticals, Inc No price found

General Counsel

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Oct 25
Form 4
—
0
—
—
0
Aug 10
Form 3
—
0
—
—
0
No matching records found